ˆãŠwŽ«“T

a,b,c,d,e,f,g,h,i, j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z

‚`
@ ƒ¿ì—pi‚₳‚µ‚¢–ò—Šwj @ ƒ¿ì—p‚ƃÀì—pi‚₳‚µ‚¢–ò—Šwj
@ ƒ¿ŽÕ’f–ò @ ƒ¿‚QŽhŒƒÜ
‚`‚`‚f‚ƃŠƒXƒ‚ƒ_ƒ“iƒWƒ\ƒsƒ‰ƒ~ƒhj ‚`‚a‚o‚l:ambulatory blood pressure monitoring
‚`‚bFã˜rŽüˆÍ@/@‚`‚l‚bFã˜r‹ØˆÍ Accountability
ACE‘jŠQÜ‚Ì“ÁŽê‚ȍì—p ‚`‚b‚d‘jŠQÜ‚Ì•›ì—p/‚`‚b‚d‘jŠQÜ‚É‚æ‚錌ŠÇ•‚Žî
ACLSFadovanced cardiovascular life support ACS:acute coroanry syndrome
Action potential Activation syndrome / Activation sydrome‚ÆŽá”NŽÒ
‚`‚cFƒAƒ‹ƒcƒnƒCƒ}[•a@/‚e‚`‚c ‚`‚c95
‚`‚c‚`‚lFandrogen decline in aged male Adaptation
‚`‚c‚b‚bFantibody dependent cell cytotoxic Add-back—Ö@iŽq‹{“à–ŒÇj
ADEM
‚`‚c‚g‚c ‚C‚„C‚C‚…@‚Ƃ́i‚₳‚µ‚¢–ò—Šwj
‚`‚c‚e‚q—Ö@ Adherence
ADL AEDFautomated external defibrillator
AF:amaurosis fugax ‚PD‚T|‚`‚f
‚`^‚f”ä ‚`‚fFanion gap
AGARICUS AGEFAdvanced glcation endproducs
@ AGL@/@‚`‚f‚l‚k @ ‚`‚f‚oFƒ¿‚PŽ_«“œ’`”’Ž¿
‚`‚g‚b‚b AHI:Apnea Hypopnea index
‚`‚h‚`F‰ð”M’Á’ɍܚb‘§ ‚`‚h‚c‚rŽ¡—Öò
‚`‚h‚g ‚`‚h‚g‚`Fautoimmune hemolytic anemia
‚`‚h‚n‚m:anterior ischemic optic neuropathy ‚`‚j‚hiacute renal injuryj
@ ‚`‚k‚h@ @ ‚`‚k‚jFanaplastic lymphoma kinase
‚`‚k‚kF¬l‹}«ƒŠƒ“ƒp«”’ŒŒ•a all or none‚Ì–@‘¥i”D•w‚Ö‚Ì–ò•¨‚̉e‹¿j
‚`‚k‚o Allele
Allostasis ‚`‚k‚sA‚`‚r‚s
Ambivalence AMDFage-related macular degeneration
‚`‚m‚b‚` Anergy
‚`‚m‚o(atrial natriuretic polypeptide) ‚`‚n‚r‚cFadult-onset Still's disease
‚`‚o‚b ‚`‚o‚c
Aposciƒ|ƒXƒgƒRƒ“ƒfƒBƒVƒ‡ƒjƒ“ƒO) APP:ƒAƒ~ƒƒCƒh‘O‹ì‘Ì’`”’Ž¿
APS ‚`‚p‚n‚k
‚`‚q‚c‚r AR-JPFíõF‘Ì—ò«ˆâ“`«Žá”N«ƒp[ƒLƒ“ƒ\ƒ“•a
Artery to arteryÇð Assertion
Assessment, evaluation, appraisal ASO
‚`‚s‚b^‚c‚c‚cƒVƒXƒeƒ€ ‚`‚s‚oŠ´Žó«‚jƒ`ƒƒƒ“ƒlƒ‹ / ‚`‚s‚oŠ´Žó«•p”
‚`‚s‚l—Ö@(’×ᇐ«‘å’°‰Šj Atypical antipsychotics
‚`‚t‚b@/‚`‚t‚h‚bFarea under the inhibitory time curve ‚`‚t‚c
‚`‚•‚„‚‰‚” Awakening
‚a
ƒÀƒV[ƒg\‘¢‚ƃAƒ‹ƒcƒnƒCƒ}[•a
@ ƒÀ-D-ƒOƒ‹ƒJƒ“»ÜiƒŒƒ“ƒ`ƒiƒ“j‚ÌŠ´Žó« @ ‚aŒ^ŠÌ‰Š‚Ì—\–h@/ ‚aŒ^ŠÌ‰Š‚Ƀ‰ƒ~ƒuƒWƒ“
@ ƒÀì—pi‚₳‚µ‚¢–ò—Šwj @ ƒÀŽ_‰»
@ ƒÀ3Žó—e‘̂Ɣ얞 @ ƒÀƒ‰ƒNƒ‰ƒ€ŠÂi‚₳‚µ‚¢–ò—Šwj
@ ƒÀŽÕ’fÜ‚Ì“äi–³‘ÊŒû–ò—Šwj @ Babinski's reflex
‚a‚`‚cFbranch atheromatous disease Basal-bolus—Ö@
‚a‚a‚aF”]-ŒŒ‰tŠÖ–åi‚₳‚µ‚¢–ò—Šwj@/@‚a‚a‚a‚Å‚Ì—A‘—ƒVƒXƒeƒ€ ‚a‚b‚fፍ­‚Æšb‘§‚ÌŠÖŒW
B‚b‚lF‚aiochemical modulation BEFBase Excess
BEEFŠî‘b‘ãŽÓ”M—Ê
‚‚‚e‚f‚e ‚a‚h‚c‚r
Biohazard Blood access
BLSFbasic life support BMI
‚a‚l‚t ‚a‚m‚oFbrain natriuretic peptide
‚a‚n‚c‚d@indexi‚b‚n‚o‚cj Bolus
‚a‚n‚s—Ö@ibasal supported oral therapyj BPH‚ÆOAB
BPPV BPSDFbehavioral and psychological symptoms of dementia
BRCA1 Breakpoint MIC
BreakthroughiR^‹ÛÜj Breakthrough pain
@ BRONJ:bisphosphonate-related osteonecrosis of the jaw @ @
Bridging sutudy BRM
BrugadaÇŒóŒQ ‚a‚r‚dF‹¶‹•a
‚a‚s‚kFbacterial translocation ‚a‚t‚m
‚b
‚bƒyƒvƒ^ƒCƒh ‚bŒ^ŠÌ‰Š@@/@‚bŒ^ŠÌ‰Š‚̍ŋ߂̎¡—Ö@
‚bŒ^ŠÌ‰Š‚Ì—\–hiˆã—Ï]Ž–ŽÒ‚Ì‚½‚߂́j ‚b‚hRÜ
‚b‚ƒnƒ“ƒhƒŠƒ“ƒO ‚b‚ƒ`ƒƒƒ“ƒlƒ‹‚̃Tƒuƒ^ƒCƒvF‚b‚hRÜ‚Ì‘gD‘I‘ð«
‚ƒ‚`‚c‚o‚q CADASIL
‚b‚`‚l CA-MRSAFcomminity-acquired MRSA
CAP CAPD:Continuous Ambulatory Peritoneal Dialysis
Carbo-hydrate Counying Carbon nanohorn:CNH
‚b‚`‚q‚r ‚b‚`‚r‚s
‚ƒ|‚b‚‚‚Œ‚Ì‹@”\‚Æ”­Šà ‚b‚b‚c‚r
‚b‚b‚d ‚b‚b‚jFCholecystokinin
‚b‚ƒ‚’ ‚b‚c‚r:contact dermatitis syndrome
CDSFCore Data Sheet Central sensitization
Central pontine myelynolysis Cerebral salt-wasting sydrome
CFS CGAFcomprehensive geriatric assessment
CGMFŽ‘±ŒŒ“œƒ‚ƒjƒ^[ ‚b‚f‚q‚oFƒJƒ‹ƒVƒgƒjƒ“ˆâ“`ŽqŠÖ˜Aƒyƒvƒ`ƒh
CHD Child]Pugh•ª—Þ
Chronic Daily Headache ChronopharmacotherapyiChronotherapyj
Churg-StraussÇŒóŒQ ‚b‚h‚c‚o
‚b‚i‚c ‚b‚jiƒNƒŒƒAƒ`ƒ“ƒLƒi[ƒ[j@/‚b‚o‚jiƒNƒŒƒAƒ`ƒ“ƒzƒXƒzƒLƒi[ƒ[j
‚b‚j‚cFV‚µ‚¢t‘Ÿ•a‚ÌŠT”O CKD-MBD
Claudin-5 Clockwise hysteresis loopŒ»Û
Clostridium difficile
‚b‚l‚kF–«œ‘«”’ŒŒ•a CNS
Cofactor•a Common disease
‚b‚‚‚‚‚Ž ‚s‚™‚‚…‚Q“œ”A•aˆâ“`Žq Comorbidityi“®–¬d‰»«Ž¾Š³‚ł́j
Compassionate use Compromised host
‚b‚n‚o‚ci‹C“¹‰ß•q«‚Æ’vŽ€—¦j ‚b‚n‚o‚c‚Æ‹CŠÇŽxšb‘§‚̈Ⴂ
‚b‚n‚o‚c‚Ì•ª—ށi•a‘Ô‚É‚æ‚éj ‚b‚‚’‚‚Ž‚‚’‚™@‚r‚”‚…‚‚Œ
Cost-effective Analyses Counterfeit medichines
Cough tic‚ƐSˆö«ŠPšu
‚b‚n‚w @/ ‚b‚n‚w|‚Q /@COX‚Q(ŠàŽ¡—Áj /@‚b‚n‚w|‚R ‚b‚n‚w|‚Q‘jŠQÜ‚ª‰ŠÇ‚ðˆ«‰»‚³‚¹‚éH
‚b•‚o–ò—ð CPAPFcontinuous positive airway pressure
CPAOA@i‚b‚o‚`j CPM:centoral pontine myelinolysis
‚b‚o‚oFƒJƒ[ƒCƒ“ƒzƒXƒzƒyƒvƒ`ƒh ‚b‚o‚qFS”x‘h¶–@
CR:Caloric RestrictioniƒJƒƒŠ[§ŒÀj ‚b‚q‚`ÇŒóŒQ
CRBSIFcatheter-related bloods tream infection ‚b‚q‚bFclinical research@coordinator
CRESTÇŒóŒQ ‚b‚q‚nFcontract research organization
Cross-section study Cross-presentation
‚b‚q‚o@@^@‚b‚q‚o‚Æ“®–¬d‰»
‚b‚q‚o‚rFComplex Regional Pain Syndorome Crush syndrome
‚brypticƒyƒvƒ`ƒh ‚b‚r‚cF”L‚ЂÁ‚©‚«•a
CSF ‚b‚r‚h‚h
CSM:confined space mediciniŠ¢âI‚̉º‚̈ã—Áj CTL
‚b‚s‚q ‚b‚s‚yFchemorescptor trigger zone
‚b‚t‚` ‚b‚x‚o
cysLT Cytoproyection
‚c
D-ƒAƒ~ƒmŽ_@/@D-ƒZƒŠƒ“‚Æ“‡Ž¸’²Ç DAA‚“
‚c‚`‚r‚gH
Danger‰¼à ‚c‚‚—‚Ž ‚o‚ˆ‚…‚Ž‚‚‚…‚Ž‚‚Ž
‚c‚a‚hFƒWƒAƒ[ƒpƒ€Œ‹‡‘jŠQ’`”’Ž¿ DCAFdichloroasetateiƒAƒ‹ƒJƒŠ‰»Üj
‚c‚bƒƒNƒ`ƒ“—Ö@ ‚c‚b‚l
De-escalation Delayed@onŒ»Û@/@Non-onŒ»Û
Delphi method ‚c‚d‚l
de novo ‚aŒ^ŠÌ‰Š
Dental Drug Delivery SystemF‚RDS ‚c‚d‚oFƒfƒB[ƒ[ƒ‹”ro”÷—±Žq
Dermadorome ‚c‚d‚rF–òÜ—noƒXƒeƒ“ƒg
‚c‚d‚r‚h‚f‚m•ª—Þ Designers Foods  / Designer drug
DettliŽ® ‚c‚g‚aF6',7'-Dihydroxybergamottin
‚c‚g‚oFŒŒ‰t‹z’…–@ ‚c‚h‹Æ–±
‚c‚h‚b@/@‚c‚h‚b score Diffuse outbreak
‚c‚h‚g‚rFDrug-induced hypersensitivity syndrome DipperŒ^‚ŒŒˆ³
‚c LCO ‚c‚k‚e
‚c‚k‚h‚rFƒWƒSƒLƒVƒ“—l–Ɖu”½‰ž•¨Ž¿
DLST ‚c‚k‚s‚Æ‚l‚s‚c
‚c‚l‚`‚q‚c‚“ ‚c‚l‚eFƒhƒ‰ƒbƒOƒ}ƒXƒ^[ƒtƒ@ƒCƒ‹
‚c‚l‚r‚nGƒWƒƒ`ƒ‹ƒXƒ‹ƒzƒLƒTƒCƒh ‚c‚m‚`ƒ`ƒbƒv
‚c‚m‚`ƒƒNƒ`ƒ“ ‚c‚m‚`ƒgƒ|ƒCƒ\ƒƒ‰[ƒ[
Dose intensty (DI) ‚c‚n‚si‚c‚n‚s‚rj
‚c‚‚s‚rFdose-time-susceptibility DPB‚ƃ}ƒNƒƒ‰ƒCƒhŒnR¶•¨Ž¿
‚c‚o‚bFDiagnosisi-Procedure Combination@ ‚c‚o‚o-‚S`ƒWƒyƒvƒ`ƒWƒ‹ƒyƒvƒ`ƒ_[ƒ[‚S
‚c‚o‚o-‚S‘jŠQÜ‚ƃCƒ“ƒXƒŠƒ“‚Ì•¹—p
‚c‚q‚d‚`‚lˆâ“`Žq Dressingi‚ÌŽ¡—Áj
‚c‚q‚f^‚o‚o‚r  /  ‚c‚q‚f^‚o‚o‚r‚Æ‚c‚o‚b‚̈Ⴂ Drug induced-depression
DRSNPsFDrug responding SNPs Drug challenge test
‚c‚r‚o‚rFdelayed sleep phase syndrome ‚c‚r‚l
Dubin-JohnsonÇŒóŒQ ‚c‚t‚diDrug Use Evaluationj Program
‚c‚u‚sFDeep vein thrombosis Dyspepsia
‚d
EBMF‰ÈŠw“I–ò•¨—Ö@‚ÌŽÀ‘H ‚d‚a‚lŒ¤‹†‚̃^ƒCƒv @/@‚d‚a‚l‚Ì—”O
‚dBVFEpstein-BarrƒEƒCƒ‹ƒX ‚d‚aƒEƒCƒ‹ƒX‚ɂ‚¢‚Ă̍ŋ߂̒mŒ©
‚d‚b@/@‚d‚b‚o@i‹Ù‹}”ð”D–@j@ ‚d‚b‚l
‚d‚c‚T‚O ‚d‚c‚k‚e:endogenous digitalis-like factor
‚d|‚c‚’‚•‚‡ ‚d‚e
‚d‚f‚b‚f Ehrlich• …Šà
EIAFexcercised-induced asthma Empiric therapy
Emerging infectious disease EMI
ENLF‚ç‚¢«Œ‹ß«g”Á ‚…‚m‚nFŒÄ‹C’†ˆêŽ_‰»’Y‘f”Z“x
‚d‚o‚qŒø‰Ê ‚d‚qƒXƒgƒŒƒX
‚d‚q‚s¨‚g‚q‚sFƒzƒ‹ƒ‚ƒ“•â[—Ö@ ES×–E‚Ńp[ƒLƒ“ƒ\ƒ“•a‚ÌŽ¡—Ã
‚d‚r‚a‚k ‚d‚r‚v‚kFextracorporeal shock-wave lithotripsy
e-seroconversio‚Ž Ethical OTC
Euglycemic hyperinsulinemic clamp Exosome
@ ex vivoˆâ“`ŽqŽ¡—Ö@ @
F
‚e‚Q‘ÙŽ™ ‚e‚‚ƒ‚…@‚“‚ƒ‚‚Œ‚…
‚e‚a‚hŒø‰Êi–³‘ÊŒû–ò—Šwj ‚e‚a‚fF‹ó• ŽžŒŒ“œ
FcƒÃRIi‚e˜a«Žó—e‘́j ‚e‚cFfunction dyspepsia
Febril neutropenia ‚e‚d‚m‚Ffraction excretion rate of sodium
‚e‚e‚o‚ÌŽg—pŠî€ FHMF‰Æ‘°«•Ð–ƒáƒ«•Ð“ª’É
FIC index ‚e‚l‚k‚oŽhŒƒ
Food@faddism Forced diuresis:FD
Formulary free water
‚e‚s4E‚e‚s3 FTNDFƒtƒ@ƒKƒXƒgƒ[ƒ€EƒjƒRƒ`ƒ“ˆË‘¶“xƒeƒXƒg
‚e‚s‚x|‚V‚Q‚Oi“~’Ž‰Ä‘j ‚e‚s‚tFfinger-tip unit
‚†‚•F”A’†–¢•Ï‰»‘Ì”rŸ•—¦ ‚e‚w‚cFfarnesoid X receptor
‚f
@ ƒÁƒOƒƒuƒŠƒ“‘å—ʐҍ—Ö@ @ @
‚fŒ^ŠÌ‰ŠƒEƒCƒ‹ƒX G’`”’Ž¿ /‚f’`”’‹¤–ðŒ^
‚f‚`‚c ‚f‚`‚a‚`‹@”\
‚f‚`‚a‚`ƒŒƒZƒvƒ^|iƒŒƒZƒvƒ^[‚ðl‚¦‚éƒVƒŠ[ƒYj ‚f‚a‚eFGerminated barley foodstuff
GCP@/@GCP(“Őã–ò—Šwj ‚f‚dƒ‹[ƒ‹
‚f‚…‚Ž‚„‚…‚’@‚Ɓ@‚r‚…‚˜ ‚fene gun-mediated immunization
Genotype Ibi‚bŒ^ŠÌ‰Šj ‚f‚d‚q‚ci‹t—¬«H“¹‰Šj
Get SmartƒLƒƒƒ“ƒy[ƒ“ @@ Get the Answers‰^“®
‚f‚e‚n GFRFŽ…‹…‘Ìàh‰ß’l
GIFGlycemic Index GI—Ö@@/ GIK—Ö@
‚f‚h‚o:glucose-dependent insulinotoropic polypeptide ‚f‚h‚n:glucocorticoid-induced osteoporosis
‚f‚h‚r‚s Golagov‚̉¼à
Glossodynia ‚f‚k‚o|‚P / ‚f‚k‚o-‚PŽó—e‘̍쓮–ò
‚f‚n‚sA‚f‚o‚s¨‚`‚r‚sA‚`‚k‚siŠÌ‹@”\ˆÙíj ‚f‚‡U‚‚/‡Va‘jŠQÜ
GPCRiG’`”’Ž¿‹¤–ðŒ^Žó—e‘́j
GPMSP Gray syndrome
‚f‚s‚s ‚f‚u‚g‚c / (2) /i3j
GV‚kŒø‰Ê ‚f‚u‚oFgood vigilance practice
‚g
‚g‚QƒuƒƒbƒJ[‚̈À‘S« ‚g‚QƒuƒƒbƒJ[‚É‚æ‚鐸__ŒoŒnáŠQ
‚g‚`‚`‚q‚sFhighly active antiretroviral therapy ‚g‚`‚cŽÚ“xihospital anxiety depression scale)
@ ‚g‚`‚dFhereditary angioedema @ HAP
Harris-Benedict‚ÌŽ® Hand-foot syndrome
@ ‚g‚‚‚`1c @ ‚g‚a‚“A‚g‚aeA‚g‚ac@
HMB:hypersens itivity to mosquito bites ‚g‚cFŒŒ‰t“§Í
‚g‚c‚`‚b‚Ì–ðŠ„‚ÆƒeƒIƒtƒBƒŠƒ“i‚g‚c‚`‚b/‚g‚`‚sj
‚g‚c‚b‚s HEõF
‚g‚d‚k‚k‚oÇŒóŒQ Her2ƒqƒg‰»R‘Ì
Herxheimer”½‰ž ‚g‚eFŒŒ‰tàh‰ß@/@‚g‚c‚eFŒŒ‰t“§Íàh‰ß
@ ‚g‚fF @ ‚g‚ˆiƒwƒbƒWƒzƒbƒOŒo˜Hj@@
‚g‚h‚uŠ´õŽ¡—ÃÜ / ‚g‚h‚uŽ¡—Â̌´‘¥ ‚g‚h‚u—Ê‚Æ•aó‚ÌŠÖŒW
‚g‚k‚` ‚g‚k‚`‚Æ•a‹C‚ÌŠÖŒW@/ ‚g‚k‚`‚Æ‚h‚c‚c‚l
HMG-CoAŠÒŒ³y‘f‘jŠQÜ ‚g‚n‚l‚`|‚q
Homeopathy ‚g‚n‚s
HOT Study Hot flush
‚g‚o‚r ‚g‚o‚uƒƒNƒ`ƒ“
‚Q‹‚g‚o‚s ‚g‚q‚sFƒzƒ‹ƒ‚ƒ“•â[—Ö@
‚g‚q‚nFhigh reliabilty organization ‚g‚q‚uFƒqƒgƒ‰ƒCƒmƒEƒCƒ‹ƒX
‚ˆSCRP ‚g‚r‚dFoŒŒ«ƒVƒ‡ƒbƒN”]ÇÇŒóŒQ
H‚r‚d‹Ç’–@ ‚g‚r‚o
5-HTƒŒƒZƒvƒ^[ 5-HT3Žó—e‘̝hRÜ
Hugh-Jones•ª—Þ Humanin
Hunt Grade HUSF—nŒŒ«”A“ŏǏnjóŒQ
Hygiene hypothesis Hypodopaminergic state
Hysteresis loop
‚h
IADLi“¹‹ï“IADL) ‚h‚a‚rFirritable bowel syndrome
‚h‚b‚` ‚h‚b‚g
ICUÇŒóŒQ ‚h‚c‚kFintermediate density lipoprotein
‚h‚e‚h‚r:intraoperative floppy iris syndrome IFNANK—Ö@
‚h‚f‚eFƒCƒ“ƒXƒŠƒ“—l‘BˆöŽq ‚h‚g‚r•ª—Þ
‚h‚k|‚T“ÁˆÙ“Iˆâ“`Žq“]ŽÊ—}§–òiƒAƒgƒs[j ImmunonutrientsF–Ɖu•ŠŠˆ•¨Ž¿ / Immunonutrition
Incretin
Informed Assent Infusion reaction
Ino‚„i‚Œator ‚h‚m‚qFinternational normalized ratio
Intervention Inverse Agonist
Inverted-dipperi‹tƒWƒbƒp[j Inverted hyperplastic polyp
‚h‚q‚aFinstitutional review board Ischemic penumbra
Ischemic ulcer ITPF“Á”­«ŒŒ¬”ÂŒ¸­«Ž‡”Á•a
‚h‚s‚q|‚p‚n‚kFInsulin Therapy Related-Qol IUSFŽq‹{“à”ð”DƒVƒXƒeƒ€
‚h‚u‚g‚É‚æ‚é^‹Û«Šá“à‰Š ‚h‚u‚h‚f—Ö@
‚i
‚iƒJ[ƒuŒ»Ûi‚tƒJ[ƒuŒ»Ûj
JGSPFJapanase@Good@Supplying@Practice ‚i|‚q‚`‚b‚sF•ž–ò”\—Í”»’莎Œ±
K
‚U‚S|‚j‚c’`”’Ž¿ ‚jFƒJƒŠƒEƒ€i—A‰t‚Rj
‚jƒ`ƒƒƒ“ƒlƒ‹(‚jƒ`ƒƒƒ“ƒlƒ‹ƒI[ƒvƒi[) ‚jƒ`ƒƒƒ“ƒlƒ‹ŽÕ’fÜ
Keith-Wagener•ª—Þ KL-6
Kleine-LevinÇŒóŒQ KwashiorkorŒ^‰h—{Œ‡–R
‚k
L-ƒJƒ‹ƒjƒ`ƒ“ ‚k‚`‚j
‚k‚`‚r‚h‚j LBMFlean body mass
‚k‚b‚`‚oFleukocytapkeresi ‚k‚c‚T‚O
‚k‚c‚kƒOƒŠƒP[ƒVƒ‡ƒ“ ‚k‚c‚kƒŒƒZƒvƒ^|iƒŒƒZƒvƒ^[‚ðl‚¦‚éƒVƒŠ[ƒYj
Lead time bias@/@Length bias LEARN‚̃Aƒvƒ[ƒ`
LES:Lower esophageal sphincter Living wil
Loading dose Locomotive@syndromeiƒƒRƒ‚j
‚k‚n‚e‚s ‚k‚‚‡@‚oi–û…•ª”zŒW”j
‚k‚n‚g‚`‚rFLifestyles of Health and@Sustainability ‚k‚n‚gÇŒóŒQ:late onset hypogonadism
Low-dose FP—Ö@ ‚kow T3ÇŒóŒQ‚Æ‹‘HÇ
LPRD:laryngo pharyngeal reflux disease LPRDFlaryngopharyngeal reflux disease  (2)
LUTSFlower urinary tract sympyoms ‚k‚™‚…‚Œ‚ŒÇŒóŒQ
M
@ ƒÊŽó—e‘̂ƃȎó—e‘́iƒIƒsƒIƒCƒhŽó—e‘́j@ @ ‚l‚`‚ai‚b‚`‚aj—Ö@F‘O—§‘B‚ª‚ñ‚Ì“à•ª”厡—Ã
‚l‚`‚bFmycobacterium avium complex MACFminimum alveolar concentration
‚l‚`‚b@BAR@/@‚l‚`‚b TI@/@‚l‚`‚b LMI@/@‚l‚`‚b awake MADSiƒ}[ƒYj
MAHFmalignancy associated hypercalcemia ‚l‚`‚g‚`
MALToma@i‚l‚`‚k‚sƒŠƒ“ƒpŽîj Malu@LUTSF’j«‰º•””A˜HÇó
MarasmusŒ^‰h—{Œ‡–R ‚l‚`‚q‚r
‚l‚`‚q‚s‚`Fmulti-acting receptor tageted antipsychotics ‚l‚`‚rƒXƒRƒA[
MAPi”ZŒúÔŒŒ‹…j ‚l‚a‚h:mechanism-based inhibition
‚l‚a‚s ‚l‚b‚hFmild cognitive impairment
‚l‚b‚s‚c ‚l‚cŽŽŒ±Fmicrodose study
‚l‚„‚‚Q MDS
MDT:Maggot Debridement Therapy ‚l^‚d”ä
‚‚…‚ƒ‚`iƒVƒŠ[ƒY‚l‚q‚r‚`‚ðl‚¦‚éj ‚l‚d‚ciŒõü‰ß•qÇ‚̃eƒXƒgj
‚l‚…‚„‚‰‚ƒ‚‚Œ@‚h‚Ž‚”‚…‚’‚–‚‰‚…‚— ‚l‚…‚„‚c‚q‚`@/@i‚Qj
‚l‚…‚‰‚‡‚“ÇŒó—lÇó@@/@Meige's syndrome Menopause@/@Andoropause
Metabolic Syndorome ‚‚d‚‘
‚l‚g‚b ‚l‚h‚b@^@‚l‚a‚b
Milan criteriaiƒ~ƒ‰ƒmŠî€j Milk-alkali sydrome
MMC—l‰^“® ‚l‚l‚oFƒ}ƒgƒŠƒbƒNƒX•ª‰ðy‘f/‚l‚l‚o‚̗Տ°‰ž—p
MNMSFŒŒsÄŒšpŒãÇŒóŒQ ‚l‚n‚c‚r
‚l‚n‚c‚x MOF:multiple organ faiure
Moist wound healing Morning dip
Molecular mimicryF•ªŽq‹[‘Ô ‚l‚o‚bFmutant prevention consentration
MPO-ANCAŠÖ˜At‰Š ‚l‚q‚oFMultidrug Resistance Protein
MRSA ‚l‚q‚r‚`‚̏Á“Å–@
MRSA‚É—LŒø‚ȍR¶•¨Ž¿ ‚l‚r
MSBOS ‚l‚r‚vimutant selection windowj—˜_
‚l‚s‚c‚Æ‚c‚k‚s ‚l‚t‚dFMedication Use Evaluation
‚l‚t‚rFmedically unexplained symptoms
‚m
n-6/n-3”ä‚ÆŒŒð«Ž¾Š³ ‚m‚`‚aFNocturnal Gastric Acid Breakthrough
‚m‚`‚c@/ NADPH]ƒIƒLƒVƒ_[ƒ[ ‚m‚`‚e‚k‚c
‚m‚`‚h‚n‚m:non-arteritic AION ‚m‚`‚m‚bF”ñƒAƒhƒŒƒiƒŠƒ“”ñƒRƒŠƒ“ì“®«_Œo
‚m‚`‚r‚gFnon-alcoholic steato-hepatitis ‚m‚‚r‚r‚`
‚m‚`‚sFN-acetyltransferase ‚m‚`‚s:ŠjŽ_‘•ŒŸ¸
‚m‚a‚l`Š³ŽÒˆêlˆêl‚Ì•¨Œê‚ÉŠî‚¢‚½ˆãŠw ‚m‚b‚b‚k‚rF—Տ°ŒŸ¸•W€‰»ˆÏˆõ‰ï
Neglected disease Neoadjuvant chemothrapy
‚m‚d‚q‚cFnon-erosive reflux disease NES:Night eating Syndrome
NethertonÇŒóŒQ Neuroleptanalaesia
@ Neuropathic Pain(‚m‚…‚o) @ ‚m‚e|ƒÈ‚a@/@‚m‚e|ƒÈ‚a‚Æ‹CŠÇŽxšb‘§
‚m‚f‚eFnerve growth factor NHCAP
‚m‚h‚rFnuerogenic intrapelvic syndrome Nitrogen DeathiƒiƒCƒgƒƒWƒFƒ“ƒfƒXF’‚‘fŽ€j
‚m‚j×–E
‚m‚j‚s×–E—Ö@ ‚m‚l‚c‚`hR–ò
‚m‚l‚rFneurally mediated syncope ‚m‚m‚s@^@NNTH
‚m‚n‚Ì”­Œ© ‚m‚n•úo«ƒAƒXƒsƒŠƒ“
non-24 ‚m‚n‚r
‚m‚o‚`‚r‚Q NPC/N”ä
NrampFNatural resistance associated macrophage protein ‚m‚q‚sFƒjƒRƒ`ƒ“’uŠ·—Ö@
‚m‚r‚`‚h‚csi‰ð”MEÁ‰ŠE’Á’ɍ܁j ‚m‚r‚`‚h‚c‚“‚ÌŠ´–`‚Ö‚Ì“K‰ž‚ɂ‚¢‚Ä
‚m‚r‚`‚h‚cs‚Ì‚»‚Ì‘¼‚̍ì—piRŠàì—pAR’s•ðì—pj ‚m‚r‚`‚h‚cs‚ƍ‚ŒŒˆ³ES‘Ÿ•aŠ³ŽÒ
‚m‚r‚`‚h‚csiƒAƒXƒsƒŠƒ“j•s‘ÏÇ ‚m‚r‚`‚h‚cs‚É‚æ‚鍂ƒJƒŠƒEƒ€ŒŒÇ
NSF:nephrogenic systemic fibrosisi ‚m‚r‚s
‚m‚t‚cA‚m‚t‚ci2j ‚m‚x‚g‚`Fƒjƒ…[ƒˆ[ƒNS‘Ÿ‹¦‰ï‚̐S‹@”\•ª—Þ
‚n
‚n|‚P‚T‚VA‚n|‚P‚T‚Vi‚Qj ‚n‚`‚aFOverActiveBladder
‚n‚`‚b—Ö@i‚RÜ•¹—p—Ö@³”F“à—e‚̈Ⴂ‚ɂ‚¢‚āj ‚n‚`‚s‚o‚Ɖʕ¨ƒWƒ…[ƒX
OAS Occult bacteremia
OCD OGTT
‚nD‚c.F‹N—§«’²ßáŠQ ‚n‚c‚si•Â½–§••—Ö@j
‚n‚†‚†|‚k‚‚‚‚…‚Œ@‚t‚“‚… OL:overlap syndrome
@ ONJ:osteonecrosis of the jawiŠ{œ‰óŽ€j @ Omics based medicine@
on-target•›ì—pAo‚†‚†-target•›ì—p One airaway,one disease‚Ƃ́i‰Ô•²Ç‚Æšb‘§j
On-OffŒ»Û Oligonephropaty‰¼à
‚n‚o‚`‚s Opioid switching & rotation
‚n‚o‚miƒIƒXƒeƒIƒ|ƒ“ƒ`ƒ“j ‚n‚q‚rioŒŒ«‘å’°‰Š‚ÌŽ¡—Ö@j/@‚n‚q‚s(ŒoŒû•â‰t—Ö@)
Orphan drug OSASF‡–°Žž–³ŒÄ‹zÇŒóŒQ@/OSAHS
OTC:Žs”Ì–ò OTC:ornithine transcarbamylase@deficiency
Out come Outbreak
overt-DIC
‚o
‚oF–û…•ª”zŒW”i‚k‚‚‡@‚oj ‚’l
‚‚P‚Pi—}‚¤‚ó‘Ԃ𔽉f‚·‚镪Žqj
‚o‚T‚Rˆâ“`Žq ‚o‚`iŒ´”­«ƒAƒ‹ƒhƒXƒeƒƒ“Çj
‚o‚`‚c‚`‚lF’j«X”NŠúáŠQ ‚o‚`‚d^time above MIC
PAIT Palliative care
‚o‚`‚l‚o(pathogen associated molecular pattern) Pradoxical reactionFŠïˆÙ”½‰ž
Parkin Pasteurizationi’ቷŽE‹Û–@j
‚o‚`‚r‚l‚d Patient's Eyes
‚o‚a‚bFŒ´”­«’_`«ŠÌ‰Š ‚o‚a‚r‚b‚s
‚o‚b‚`FŠ³ŽÒŠÇ—’Á’Ɂi–³’Ɂj–@ ‚o‚b‚b
‚o‚c‚`Fpatent ductus arteriosus ‚o‚c‚d‚h FƒtƒHƒXƒtƒHƒfƒBƒGƒXƒeƒ‰[ƒ[‘jŠQÜ
‚o‚c‚f‚e ‚o‚c‚m
‚o-Drug ‚o‚c‚rFperiodic synchronous dischstge
‚o‚c‚sFphotodynamic therapy ‚o‚dFpulmonary embolism
PEACS:phamacist's evaluation and analysis check system
‚o‚d‚b‚n Peaks•Valleys
Peer@review ‚o‚d‚e
‚o‚d‚fFŒo”ç“àŽ‹‹¾“IˆÝᑑ¢Ýp ‚o‚d‚f|‚h‚e‚m
PEIT ‚o‚d‚lFPrescription-Event Monitoring
‚o‚d‚lFprotein energy malnutrition Perfomance staus
‚o‚…‚’‚‰‚‚„‚‚Ž‚”‚‚Œ@‚l‚…‚„‚‰‚ƒ‚‰‚Ž‚… ‚o‚d‚sFpositron emission tomography
‚o‚f‚o`‚o“œ’`”’Ž¿ ‚o‚e‚bi‘ÙŽ™zŠÂŽ‘±Çj
‚o‚e‚bƒoƒ‰ƒ“ƒXi‰h—{j ‚o‚e‚cŽŽŒ±
‚o4‚oFPay for performance ‚o‚f‚qFprandial glucose regulator
‚o‚f‚˜FPharmacogenomics
PH:Pulmonary Hypertension Phagocyte delivery
‚o‚g‚`‚q‚l-‚Q‚d Pharmacogenomics
Pharmacovigilance PhenocopyŒ»Û
‚o‚g‚h:pregnancy induced hypertension Physica‚Œ@assessment
Phytoremediation
Piggy-back study PK/PDƒ‚ƒfƒŠƒ“ƒOiPK/PD—˜_j
‚o‚h‚dÇŒóŒQiŠÔŽ¿«”x‰Šj ‚o‚k–@i‚PjAi‚QjAiŒŒ‰t»Ü‚́j
‚o‚k‚aFƒzƒXƒzƒ‰ƒ“ƒoƒ“ ‚o‚k‚cFphospholipidosis
‚oleiotropic effct ‚o‚k‚l‚rFŽüŠú«ŽlŽˆ‰^“®áŠQ
‚o‚lF¶‚Ü‚ê‚‚«–ò‚ÉŽã‚¢l ‚o‚l‚c‚cFpremenstrual dysphoric disorder
‚oM I PMSFPost Marketing Surveillance
‚o‚l‚rFPremenstrual Syndorome Polypill@strategy‚Æ‚Í
‚o‚n‚m‚P Polypathy
POS(Problem Oriented System),POMR ‚o‚n‚s‚rFPostural orthostaic tachycar@syndrome
‚o‚n‚r‚r‚h‚a‚k—˜_iŠÉ˜aˆã—Áj ‚o‚o‚`FƒtƒFƒjƒ‹ƒvƒƒpƒm[ƒ‹ƒAƒ~ƒ“i•›ì—pj
‚o‚o‚`‚qƒÁ‚ƃ`ƒAƒ]ƒWƒŠƒ“—U“±‘Ì ‚o‚o‚h@/@‚o‚o‚h‚̏ˆ•û“ú”
@ ‚o‚o‚h‚Å•›•@o‰Š‚ªŽ¡–ü @ ‚o‚o‚h‚Ö‚Ì‹t•—
@ ‚o‚o‚hƒeƒXƒg @ PPMFPotluck Party Method@
‚o‚o‚mFPost-treatment painful neuropathy ‚o‚o‚mF––½Ã–¬‰h—{–@
‚o‚p‰„’· ‚o‚p‚p:pyrroloquinonlinequnone
Pregnancy loss Procalcitonin
‚o‚q‚nFpatient-reported outcomes ‚o‚q‚n‚a‚dŽŽŒ±
Probiotics ‚o‚q‚ji‚q‚jj
Prospective study Protein sparing effect
‚o‚q‚r‚o ‚o/‚r”ä
PSAFprostate specific antigen@/ ‚o‚r‚`ŒŸf‚Í‹^–â ‚o‚r‚fŒŸ¸
Psychoeducation ‚o‚s‚b‚`@/@PCI
‚o‚s‚dFpulmonary thromboembolism PTH-rPiœ‹zŽû‘£iˆöŽqj
‚o‚s‚oŒëŸZ‚ÌŒ»ó‚Ƒ΍ô ‚o‚t‚e‚`
Pulmonary cachexia PUVA—Ö@
‚o•¨Ž¿‚ƕГª’É‚ÌŠÖŒW ‚o“œ’`”’Ž¿‚Æ–ò•¨‘ŠŒÝì—p
‚o“œ’`”’‚ƃgƒ‰ƒ“ƒXƒ|[ƒ^[ ‚o“œ’`”’Ž¿‚É‚æ‚é–òÜ‘ϐ«‚̍Ž•ž
‚p
‚p”M QALYFQuality-adjsted Life Year
‚p‚hFqualty indicator / ‚p‚h‚ÌŽw•Wˆê—— ‚p‚q‚r‰„’·
Q‚rƒVƒOƒiƒ‹ FQuorum sensing ‚p‚s‰„’·
‚p‚sƒfƒBƒXƒp[ƒWƒ‡ƒ“ ‚p‚n‚k‚Ì‘ª’è–@
Quality of Lifei~ˆ³Ü‚́j Quorum sensing
R
R@Ratio
RAD-AR ‚q‚`‚m‚j‚k
R-CPCFReversed Clinico-Pathological Cnference ‚q‚b‚s
RDS Red neck(red man)ÇŒóŒQ
Readiness ‚qefilling Prescription
‚q‚…‚‰‚”‚…‚’ÇŒóŒQ Reverse geneticsF‹tˆâ“`Šw
Reye—lÇŒóŒQ Respiratory quinolone
RFAFŒo”ç“Iƒ‰ƒWƒI”gÄŽÜ—Ö@ Rhabdomyolysis
Ribonucleic acid Ribosome
RLS:restless legs syndrome ‚q‚m‚`Š±Â
Root Cause AnalysisFˆã—ÃŽ–ŒÌ–hŽ~ RTCFRound the Clocki‹CŠÇŽxšb‘§j
RTP:rapid turnover protein Rubinstein-TaybiÇŒóŒQ
S
SAARD ‚r‚`‚c:social anxiety disorder
SAHS:sleep apnea hypopnea syndrome@/@SAS ‚r‚`‚l‚lFsafety assessment of marketed medicines
Sarcoma@180 Sarcomere
‚r‚a‚n‚d ‚r‚b‚cFsystemic contact dermatitis
‚r‚b‚cFspinocerebellar degeneration ‚r‚b‚h
SCN ‚r‚b‚sF‘¢ŒŒŠ²×–EˆÚA—Ö@
SCU ‚r‚c‚`FƒZƒƒgƒjƒ“-ƒhƒpƒ~ƒ“-ƒAƒ“ƒ^ƒSƒjƒXƒg
SDMFShared Decision Making ‚r‚c‚r
@ Self-efficacy @ @
Selection biasiŽ©ŒÈ‘I‘ðƒoƒCƒAƒXj Septic MOF
‚r‚d‚q‚l Sensitivity(Š´“xj/Specificity(“ÁˆÙ“xj
Seroconversio‚Ž ‚r‚e‚R‚U`‚p‚n‚k‚Ì‘ª’è–@
‚r|‚f‚d‚q‚c ‚r‚f‚`Fsubjective global assessment
@ SGA(small for gestational age) @ ‚r‚f‚l‚k@
‚r‚h‚`‚c‚g Sick day
‚r‚h‚c‚r si‚q‚m‚`‚Æ‚q‚m‚`i
‚r‚h‚o`‚p‚n‚k‚Ì‘ª’è–@ ‚r‚h‚q‚r
‚r‚h‚r‚hƒeƒXƒg ‚r‚i‚rFStevens-JohnsonÇŒóŒQ
‚r‚k‚d ‚r‚k‚oƒeƒXƒgiŽüpŠú‚ÌŠ´õ—\’mj
Smad Small baby syndrome
@ smallRNA(miRNA),siRNA,piRNA) @ @
SMBG ‚r‚l‚nFsite management organization
Sm‚’Gsmall multidrug resisitance gene ‚r‚l‚rFSymptom-Medication Score
‚r‚m‚kFƒZƒ“ƒ`ƒlƒ“ƒ^ƒ‹ƒŠƒ“ƒpß ‚r‚m‚oi‘ãŽÓ‘½Œ^‚Rj
SNRI ‚r‚n‚`‚o
‚r‚n‚c Somatic mutation
SomogyiŒ»Û ‚r‚o‚``––½i_ŒojŽhŒƒ—Ö@
‚r‚o‚cFsupply processing and distribution ‚r‚o‚h‚c‚c‚l
‚r‚o‚lF•‚—V—±Žqó•¨Ž¿ ‚r‚q‚rFslow reacting substance`ƒƒCƒRƒgƒŠƒGƒ“
‚r‚q‚r‚ui¬Œ^‹…Œ`ƒEƒCƒ‹ƒXj ‚r‚rFsalt-sensitiveŒQ‚Æ‚m‚r‚riŒŒˆ³j
‚r‚r‚hFsurgical site infection ‚r‚r‚q‚h‚Ì–â‘è“_ / ‚r‚r‚q‚h’†’fÇŒóŒQ
‚r‚r‚q‚h/‚r‚m‚q‚h‚Æ‘¼ŠQsˆ×‚ɂ‚¢‚Ä ‚r‚r‚q‚h‚̍R‚¤‚ì—p‚ª’É‚ÝŽ~‚ß‚ÅŒ¸Žã
‚r‚r‚o(silver spike point)—Ö@`Žh‚³‚È‚¢èI
@ ‚r‚s‚c @ Stiffness@
Stiff-manÇŒóŒQ St.John's Wort
Stevens-JohnsonÇŒóŒQ ‚r‚s‚q‚d‚r‚r‚É‚æ‚éƒXƒgƒŒƒX‚̉ðÁ–@
StreamliningiDe-escalation)
‚r‚tÜFƒXƒ‹ƒzƒjƒ‹”A‘fÜ‚̍ì—p‹@˜ ‚r‚tÜ‚Ì“ñŽŸ–³Œø
‚r‚•‚‚|‚l‚h‚b ‚r‚u‚qFsustained virological response
‚s
‚s‚c‚l/ ‚s‚c‚l‚ª•K—v‚Æ‚³‚ê‚éê‡ ‚s‚d‚mF’†“Ő«•\”ç‰óŽ€Ç
‚s‚d‚pGtoxic equivalents ‚s‚fFƒgƒŠƒOƒŠƒZƒŠƒh
@ ‚s‚f‚e|ƒÀ @ ‚s‚ˆ‚P^‚s‚ˆ‚Qƒoƒ‰ƒ“ƒX
Therapeutic window Third diseasei“‡Ž¸’²Çj
Thrifty phenotype‰¼à ‚s‚h‚`FTransient ischemic attack
Tight junction time@above@MIC
TLRFToll-like ReceptoriToll—lŽó—e‘́j TLR‚ƃAƒŒƒ‹ƒQƒ“
@ TLS:Tumor Lysis Syndorome @ @
@ ‚s‚m‚e|ƒ¿@/@‚s‚m‚e|ƒ¿‚ƃNƒ[ƒ“•a @ ‚s‚m‚l•ª—ށiŠàj
‚s^‚o”ä ‚sorsades@de@pointes
Toxic Shock Syndrome TPR:Total peripheral resistance
‚s‚o‚m‚Ì“K—p‚ƍ‡•¹Ç ‚s‚o‚m‚Ætranslocation
‚s‚r‚d ‚s‚r‚eFã˜rŽO“ª‹Ø•””牺Ž‰–b
‚s‚q‚`‚k‚hFTransfusion-Related Acute Lung Injury Transformation`‚o‚q‚r‚o‚̑ϐ«ƒƒJƒjƒYƒ€
 TRPV1 TTƒEƒCƒ‹ƒX
TTP(ƒpƒiƒ‹ƒWƒ“ùj TTPFtime to progression
T×–E‚Ì•ª—ށiƒTƒCƒgƒJƒCƒ“‚É‚æ‚éCD4j Triggered activityi•s®–¬j@
Tumor dormancy‚©‚ç‚Ý‚½Šà‰»Šw—Ö@ Tumor Lysis Syndorome
Two-stateƒ‚ƒfƒ‹FƒCƒ“ƒo[ƒXƒAƒSƒjƒXƒg Type and ScreenFŒŒ‰tŒ^•s‹K‘¥R‘̃XƒNƒŠ[ƒjƒ“ƒO–@
‚t
‚tƒJ[ƒuŒ»Ûi‚ŒŒˆ³j ‚t‚b‚oFUncoupling protein
Unani medicine ‚t‚o‚c‚q‚rFUnified parkinson's disease rating scale
‚t‚o‚rFƒ†ƒrƒLƒ`ƒ“EƒvƒƒeƒAƒ\[ƒ€ƒVƒXƒeƒ€ Upstream approach
‚u
‚u‚`‚r Vaughan Williams•ª—ށi•s®–¬j
‚u‚„ ‚u‚o‚cFvaccine preventable diseases
‚u‚…‚’‚“Å‘f ‚u‚g‚k•aivon Hippel-Linday:VHLj
‚u‚h‚oFŒŒŠÇì“®«’°ŠÇƒyƒvƒ`ƒh Vibrio vulnificus(V.v)
‚u‚q‚PŽó—e‘Ì ‚u‚q‚diƒoƒ“ƒRƒ}ƒCƒVƒ“‘ϐ«’°‹…‹Ûj
‚u‚q‚r‚`iƒoƒ“ƒRƒ}ƒCƒVƒ“‘ϐ«‚l‚q‚r‚`j ‚u‚s‚dFvenous thromboembolism
‚v
‚v‚a‚f‚s‚Æ”M’†Ç—\–h ‚v‚a‚o‚ÉŠî‚­–«‘n‚ÌŽ¡—Ã
Wearinng-offŒ»Û
Wellnes Whipple‚Ì‚R’¥Œó(’ጌ“œ‚̐f’f)
White-coat effect Window period
W‚‰‚Ž‚„@‚•‚Œ»Û Wolff-ChaikoffŒø‰Ê
Women's Health workaholic
‚x
YITF–î’ǃCƒ“ƒpƒNƒg—Ö@
‚y
Zollinger-EllisonÇŒóŒQ

@


y–³‘ÊŒû–ò—Šwz

y‚₳‚µ‚¢–ò—Šwz y“Őã–ò—Šwz y–ò•¨î•ñ’ñ‹Ÿ‚ðl‚¦‚éz

MonkeyBanana2.Com Free Counter

‚ ‚¢‚¤‚¦‚¨‡õˆø‚Ö